Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ceska

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Vnitrni Lekarstvi|February 1, 1988
[Ischemic heart disease and risk factors in patients with gout]S Alusík, K Pavelka, R Ceska, et al.
Casopis Lekaru Ceskych|March 25, 1988
[Hyperlipoproteinemia in patients with uric arthritis. The effect of treatment on the disease]K Pavelka, R Ceska, J Sobra, et al.
Angiology|October 6, 1997
Decreasing common carotid artery intimal thickness during hypolipidemic therapyJ Spácil, R Ceska, J Sobra, et al.
Physiological Research|January 7, 2000
Serum leptin concentrations in patients with combined hyperlipidemia: relationship to serum lipids and lipoproteinsM Haluzík, J Fiedler, J Nedvídková, et al.
Physiological Research|November 10, 2000
Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotypeT Stulc, R Ceska, A Horínek, et al.
Casopis Lekaru Ceskych|May 18, 1993
[Duolip Forte--experience during a 6-month period of administration]H Toschnerová, R Ceska, J Sobra, et al.
Casopis Lekaru Ceskych|May 17, 1995
[Simvastatin in the treatment of familial hypercholesterolemia]R Ceska, J Sobra, R Procházková, et al.
Vnitrni Lekarstvi|October 1, 1993
[Familial hypercholesterolemia from the aspect of DNA analysis]A Horínek, J Sobra, R Ceska, et al.
Vnitrni Lekarstvi|January 15, 2009
[The Atractiv project: improvement of cardiovascular preventive in primary care in the Czech Republic]M Vrablík, T Freiberger, V Lánská, et al.
Vnitrni Lekarstvi|April 1, 1990
[Etolip and Lipanthyl in the treatment of hyperlipoproteinemia]R Ceska, J Sobra, R Procházková, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Vnitrni Lekarstvi|February 1, 1988
[Ischemic heart disease and risk factors in patients with gout]S Alusík, K Pavelka, R Ceska, et al.
Casopis Lekaru Ceskych|March 25, 1988
[Hyperlipoproteinemia in patients with uric arthritis. The effect of treatment on the disease]K Pavelka, R Ceska, J Sobra, et al.
Angiology|October 6, 1997
Decreasing common carotid artery intimal thickness during hypolipidemic therapyJ Spácil, R Ceska, J Sobra, et al.
Physiological Research|January 7, 2000
Serum leptin concentrations in patients with combined hyperlipidemia: relationship to serum lipids and lipoproteinsM Haluzík, J Fiedler, J Nedvídková, et al.
Physiological Research|November 10, 2000
Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotypeT Stulc, R Ceska, A Horínek, et al.
Casopis Lekaru Ceskych|May 18, 1993
[Duolip Forte--experience during a 6-month period of administration]H Toschnerová, R Ceska, J Sobra, et al.
Casopis Lekaru Ceskych|May 17, 1995
[Simvastatin in the treatment of familial hypercholesterolemia]R Ceska, J Sobra, R Procházková, et al.
Vnitrni Lekarstvi|October 1, 1993
[Familial hypercholesterolemia from the aspect of DNA analysis]A Horínek, J Sobra, R Ceska, et al.
Vnitrni Lekarstvi|January 15, 2009
[The Atractiv project: improvement of cardiovascular preventive in primary care in the Czech Republic]M Vrablík, T Freiberger, V Lánská, et al.
Vnitrni Lekarstvi|April 1, 1990
[Etolip and Lipanthyl in the treatment of hyperlipoproteinemia]R Ceska, J Sobra, R Procházková, et al.
Pageof 12